Explore educational content from VCCC lectures, symposia and conferences to be informed of the latest developments.
Monday 9 November 2020
Monday Lunch Live with presenter Professor Ben Solomon, Peter MacCallum Cancer Centre and A/Professor Gavin Wright
Lung cancers account for more cancer related deaths than any cancer worldwide. About 3 to 5% of patients with non-small cell lung cancer have tumours with rearrangements in the anaplastic lymphoma kinase gene.
Professor Solomon discusses the phase I to III clinical trials that are dramatically improving outcomes for patients with advanced lung cancer.
Thursday 5 November 2020
RACGP and VCCC event with presenter Professor Jon Emery, VCCC Primary Care Research and Education Lead.
An expert panel share commonplace experiences in the head and neck cancer pathway - from diagnosis, presenting symptoms to management principles and follow-up care with tips on best practice care, key communication points and challenges GPs face.
Friday 6 November 2020
Cancer and COVID-19 in Victoria with presenter Dr Ziad Bakouny.
Globally, people with cancer are one of the largest groups to be impacted by COVID-19. In addition to the physical impact on patients, the delivery of cancer care and research has been severely disrupted.
Dr Ziad Bakouny, Dana-Farber Cancer Institute, Boston USA, highlights the biological interplay between the two diseases and provides practical recommendations for the treatment of patients with cancer during the pandemic.
Ziad Bakouny, MD, MSc is a post-doctoral research fellow at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute (DFCI).
Monday 26 October 2020
Monday Lunch Live with presenter Dr Jennifer McQuade, MD Anderson Cancer Centre
Immunotherapy has dramatically changed the landscape of cancer care, with numerous immunotherapeutic strategies now being implemented across the therapeutic continuum. However, despite this tremendous success, a significant proportion of patients still do not fully benefit from these therapies. Thankfully the microbiome—and the foods that feed it—is emerging as an important determinant of a patient’s response to immunotherapy, with promising outcomes.
Dr Jennifer McQuade, MD Anderson Cancer Centre reviews the gut microbiome and explains how it is an important emerging biomarker to be considered in the response to revolutionary new cancer therapies.
Wednesday 21 October 2020
Cancer and COVID-19 with presenter Professor Jon Emery, VCCC Primary Care Research and Education Lead.
COVID-19 restrictions in Victoria has led to a reduction in pathology notifications for cancer of approximately 30 per cent for the five most common cancers. These cancers represent 60 per cent of all cancer diagnoses. This webinar aims to provide support and advice to clinicians and health care services treating patients with cancer during the COVID-19 pandemic.
Leading experts discuss the role of primary care professionals in addressing community concerns during COVID-19, identifying and responding to patients presenting with a late diagnosis cancer and the consequences of delayed cancer diagnoses on the health system.
Monday 19 October 2020
Monday Lunch Live with presenters Professor Joe Trapani and Associate Professor Paul Neeson. Moderated by Professor Sharon Lewin AO.
In the past decade, adoptive immunotherapies in the form of recombinant checkpoint antibodies or chimeric antigen receptor CAR T-cells have realised a century-long quest to harness the immune system to control established cancer.
Professor Trapani, Head Cancer Immunology Program, Peter MacCallum Cancer Centre reflects on the history of CAR T-cell technology and explores strategies currently being developed to extend the range of cancers for which CAR T and related approaches can prove effective. Joined by Associate Professor Paul Neeson, Group Leader, Cancer Immunology Program and moderated by Professor Sharon Lewin AO, Director, The Peter Doherty Institute for Infection and Immunity.
Monday 12 October 2020
Monday Lunch Live with presenter Dr Orazio Vittorio
Blocking copper uptake in tumour cells may be a clue to boosting immune system - fighting the deadliest of cancers.
Dr Vittorio, Head of The Metal-Targeted Therapy and Immunology Lab at the Children's Cancer Institute NSW has identified a strong connection between copper transporters found in malignant cancer tissue compared with normal tissue (copper transporter 1 CTR-1 and PD-L1). He presents cutting-edge research that proves that chelation therapy enhances anti-tumour immune responses and could be repurposed for immune checkpoint inhibition.
Friday 9 October 2020
Cancer and COVID-19 in Victoria with Professor Jennifer Philip, Danielle Spence, Associate Professor Brian Le, Associate Professor Mark Boughey, Dr Michelle Gold, Gael Wilder and Dan Fleming
For people requiring care due to a life-limiting illness, and the healthcare workers who care for them, COVID-19 presents particularly complex physical, emotional and ethical challenges.
In this webinar a multidisciplinary panel explores the clinical, ethical and patient experience including challenges to service delivery, bridging the ethical priorities and compassionate care and the impact on patients and families.
Monday 5 October 2020
Monday Lunch Live with presenter Associate Professor Misty Jenkins
In this webinar Misty discusses her research into how CAR T-cell immunotherapy is providing an exciting new approach to enhance brain cancer survival rates.
The presentation covers the generation and testing of two novel chimeric antigen receptor T cells. The first targets EGFRvIII, which serves as an attractive therapeutic target for glioblastoma given its exquisitely tumour specific expression.
Monday 29 September 2020
Monday Lunch Live with Associate Professor Fiona Simpson
Associate Professor Fiona Simpson is a Fellow of the Queensland Head and Neck Cancer Centre. Her lab focuses on the translation of research findings into new cancer therapies and have recently generated an exciting new method for antibody-mediated cancer therapy. This breakthrough method reduces tumour target variation, reversing drug resistance and increasing drug targeting to tumour cells.
Hosted by Professor Mark Rosenthal, Peter MacCallum Cancer Centre, Fiona discusses findings of her labs recently completed Phase IB safety trials.
Thursday 3 September 2020
Clinical application of genomics with chair Ben Markman and various presenters.
Genomic literacy is increasingly important for oncologists.
This symposium provides insights into the clinical implementation of assays and how it can improve treatments. Genomics-based assays are increasingly used to guide clinical decision-making to select the most appropriate targeted therapy for patients. Listen to experts who share their knowledge on basic science and genetics, how to implement assays and the importance of patient consent. Molecular pathology reports are also dissected and explained.
Friday 11 September 2020
Cancer and Covid-19 in Victoria. Professor Eva Segelov, Director of Oncology, Monash Health, moderates a consumer and expert panel discussion about clinical trials during COVID-19.
Clinical trials are a critical element of progressive, evidence based cancer research and can provide access to cutting edge treatments for patients. This educational forum explores the challenges and opportunities that metropolitan and regional trial participants are facing during the COVID-19 pandemic, and the measures and innovations that have helped to keep trials running through this period.
Monday 7 September 2020
Monday Lunch Live with presenter Professor Dean Lusher.
Social network analysis (SNA) is a way of examining social connections allowing us to understand their patterns and implications. Social network analysis provides a framework for understanding social connectivity, and it is much more than just a method of analysis. It requires theory – an understanding of the reasons why we connect – to understand the structures of networks.
Professor Dean Lusher, Head of the Social Network Research Laboratory, Swinburne University, introduces Social Network Analysis (SNA) methods and explains how deeper understanding of social networks can be leveraged to benefit your work.
Monday 31 August 2020
Monday Lunch Live with Dr Simon Chu, Research Group Head of the Hormone Cancer Therapeutics Laboratory at the Hudson Institute of Medical Research in Melbourne
Dr Chu is an expert in ovarian granulosa cell tumours (GCT), a unique subset of deadly ovarian tumours.
His studies are focused on understanding the molecular mechanisms which contribute to the pathogenesis of GCT and may present novel therapeutic targets.
Dr Chu's presentation outlines what is known about this disease, the difficulty in treating it and how research aims to dissect the mechanisms which contribute to the development of GCT.
Friday 28 August 2020
Cancer and COVID-19 in Victoria. Professor Clare Delany, Clinical Ethicist at the Royal Children’s Hospital and Peter MacCallum Cancer Centre leads a thought-provoking panel discussion on the complexities of care and clinical ethics during COVID-19.
From the temporary pause of some cancer screening and research, to the restriction of visitors in hospitals, the COVID-19 global pandemic has profoundly affected the way cancer care is delivered, researched and experienced.
Drawing from real case examples, this informative webinar presents a range of ethical challenges encountered by cancer clinicians during the COVID-19 pandemic.
Monday 3 August 2020
Monday Lunch Live with Professor Gail Garvey
In this much anticipated presentation for 2020, Professor Garvey outlines research and key considerations to support the delivery and optimal care for Aboriginal and Torres Strait Islander people living with cancer.
A growing body of research has reported the significant disparities in cancer outcomes between Indigenous and non-Indigenous Australians, in part a result of factors relating to the accessibility, acceptability and effectiveness of health services. Although there is increasing awareness of these disparities, targeted culturally appropriate strategies to address these have been slow. Relatively little attention has been directed towards identifying and focusing on the psychosocial aspects of cancer for Indigenous patients, a critical component in improving cancer care and outcomes.
Monday 10 August 2020
Monday Lunch Live with Dr Luciano Martelotto
Single cell and single nucleus genomics offer the amazing opportunity to enhance the resolution of our understanding of biology. However, successful experimentation is only possible when every step is done properly.
Dr Luciano Martelotto, Scientific Director of the Single Cell Core at the Laboratory of Harvard Medical School, explains critical factors to consider from sample accrual and storage, to sample processing and sequencing. He shares best practice of single cell genomics for researchers to take back to their labs.
2 & 3 July 2020
Know your blood with co-convenors Andrew Roberts and Piers Blombery and various presenters.
Understanding and applying genomic results in haematological disorders.
Advances in understanding the genomic landscape of haematological disorders mean that we are closer than ever to a precision medicine approach to managing individual patients. Improved understanding of molecular diagnostics to inform decision-making in treatment selection and prognosis is a priority for health care practitioners. Hear from experts discussing recent advances in the genomic classification of myeloproliferative neoplasms, acute lymphoblastic leukemia, lymphoma and marrow failure.
Monday 6 July 2020
Monday Lunch Live with Associate Professor Lesley Stafford, Dr Toby Winton-Brown and Dr Kym Jenkins, Dr Maria Ftanou.
A panel of mental health experts explore the emotional needs and responses of healthcare workers during a public health crisis.
Associate Professor Stafford, Clinical Psychologist at the Royal Women's Hospital moderates an expert panel from Alfred Health, Council of Presidents of Medical Colleges and Peter MacCallum Cancer Centre to explore findings from surveys conducted with frontline healthcare workers during COVID-19 and offer techniques for supporting and leading during challenging times.
Monday 13 July 2020
Monday Lunch Live with Dr Sarah Best, Dr Simon Keam and Dr Jessica da Gama Duarte.
Emerging cancer researchers share exciting developments in basic, translational and clinical research.
Postdoctoral researchers from across the VCCC Alliance join Dr Clare Fedele to showcase their latest research in therapeutic approaches to treating lung cancer, a novel blood test to predict immunotherapy response and using radiation therapy to boost immune responses in prostate cancer.
Friday 15 May 2020
COVID-19 and Cancer in Victoria with presenter Associate Professor Zee Wan Wong, Medical Oncologist, Peninsula Health.
As a response to COVID-19, telehealth has been taken up rapidly. Given the fast pace of change, the sector is responding to develop and implement ‘how to’ guides and best practice around the implementation and use of telehealth for both health professionals and consumers.
It seems that regular use of telehealth for patient consultations will be part of the 'new normal' across health care once the pandemic subsides.
In this special panel presentation, expert speakers will provide practical strategies for enhancing telehealth communication skills via phone and video consultation.
Monday 11 May 2020
Monday Lunch Live with presenter Associate Professor Ian Collins and various presenters.
Cancer clinical trials are also experiencing a delivery revolution; adopting the teletrial model to implement trials across multiple sites.
Ian is joined by Professor Sabe Sabesan, Kathleen Wilkins, Dr Craig Underhill, Cheryl-Ann Hawkins and Melanie Poxton to discuss National teletrial activity and next steps, teletrial impact for a regional patient and how the teletrial model is implemented?
Monday 4 May 2020
Monday Lunch Live with various presenters.
A panel of experts explore the processes of advance care planning, provide communication tips to assist hard conversations, and share supportive resources for clinicians.
Having conversations with patients and their families, and the development of Advance Care Directives can be beneficial to cancer care. Yet research demonstrates only fifteen percent of Australians aged over 65 years with cancer have documented an Advance Care Directive. Professor Jennifer Philip, Chair of Palliative Medicine at the University of Melbourne, moderates our fourth interactive forum on COVID-19 and Cancer in Victoria.
Monday 27 April 2020
Monday Lunch Live with Dr Irene Wagner and Dr Ranjana Srivastava.
Holistic care of the increasingly large elderly population with cancer is an area that concerns all of us.
Dr Irene Wagner, an expert in dementia and the residential aged care system, and Dr Ranjana Srivastava an oncologist who founded the Monash Geriatric Oncology Service are actively involved in shaping the future of geriatric oncology in Victoria. They discuss some key lessons from their geriatric assessment experience and provides tips to clinicians interested in providing holistic healthcare to cancer patients in an ageing society.
16-17 September 2019
VCCC Research Conference with Professor Kate Burbury, Peter MacCallum Cancer Centre
Digital health: Australia-wide expansion of clinical trials
A/Professor Kate Burbury is a consultant haematologist and Deputy Chief Medical Officer at Peter McCallum Cancer Centre. She is the lead clinician for MPN/CML, as well as the haemostasis/ thrombosis service and peri-procedural optimisation, including prehabilitation, for patients at PeterMac. Kate is also the clinical and content lead for digital health and strategy for building regional partnerships around Victoria and interstate.